Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

Vertexs

FDA Greenlights Vertex’s Non-Opioid Pain Relief Drug, Journavx

January 30, 2025
FDA approves Vertex non-opioid painkiller drug Journavx

Vertex Pharmaceuticals Sets a New Standard in Pain Management with FDA Approval of Non-Opioid Painkiller In a groundbreaking moment for pain management solutions, Vertex Pharmaceuticals has received FDA approval for its innovative non-opioid painkiller, Journavx. … Read more

Categories Business News Tags drug, FDA, Greenlights, Journavx, NonOpioid, pain, Relief, Vertexs

Categories

Recent Posts

  • Coinbase and Shopify Collaborate on USDC Payment SolutionsJune 14, 2025
  • Despite Today’s News, the Semiconductor Index Remains on Course for $5700June 14, 2025
  • These Stocks, Oracle Included, Top Wall Street’s Overbought ListJune 14, 2025
  • REJKT.XYZ: Discover a New Era of Art on TezosJune 14, 2025
  • Gold Rises as Middle East Tensions EscalateJune 14, 2025
  • Hang Seng Index Update: Trade Deal Optimism Diminishes Amid Israel-Iran Tensions – Weekly ReviewJune 14, 2025
  • Understanding Credit Cycling: How It Works and Its RisksJune 14, 2025
  • Wells Fargo Boosts Outlook on Cloud Security Leader, Forecasts 28% Growth PotentialJune 14, 2025
  • Mirandus June Update: Unveiling New Characters and ChallengesJune 14, 2025
  • Analysis: Trend Hedge Funds Face Challenges as Agile Macro Funds Adapt to Volatile MarketsJune 14, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights